Industrial Development

Fosun Pharmaceutical Industrial Development is a core subsidiary of Fosun Pharma, a leading global pharmaceutical and healthcare group based in China. The company focuses on the research, development, and industrialization of innovative medicines across key therapeutic areas including oncology, immunology, and metabolism. It operates through a diversified model of independent R&D, cooperative development, and licensing, maintaining a robust pipeline of small molecules, biologics, and advanced cell therapies. Notable programs include the co-development of FXB0871, an anti-PD1-IL2 fusion protein, and the commercialization of CAR-T cell therapies in China. The company leverages its extensive manufacturing capabilities and global distribution network to bring high-value medical solutions to patients worldwide.